Thermo Fisher (NYSE:TMO): A classic blue-chip health stock for the rest of the 2020s
Capped at over US$180bn, Thermo Fisher (NYSE:TMO) is a classic blue-chip healthcare stock. It has not escaped an impact from the…
Read MoreChalice Mining (ASX:CHN): Its got 16Moz of 3E (Palladium, Platinum and Gold combined); so why the sell off?
Chalice Mining (ASX: CHN) has been the exploration story of the decade. All of the hundreds of explorers on the…
Read MoreWill Ozempic hurt healthcare stocks? Here are 5 reasons we don’t think so
Will Ozempic hurt healthcare stocks? Investors who’ve been selling healthcare stocks left right and centre – except Novo Nordisk of…
Read More